344 related articles for article (PubMed ID: 38392851)
1. Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract.
Noh HE; Rha MS
Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392851
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immune responses to infection and vaccination in the respiratory tract.
Mettelman RC; Allen EK; Thomas PG
Immunity; 2022 May; 55(5):749-780. PubMed ID: 35545027
[TBL] [Abstract][Full Text] [Related]
3. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
[TBL] [Abstract][Full Text] [Related]
4. Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice.
Ashhurst AS; Johansen MD; Maxwell JWC; Stockdale S; Ashley CL; Aggarwal A; Siddiquee R; Miemczyk S; Nguyen DH; Mackay JP; Counoupas C; Byrne SN; Turville S; Steain M; Triccas JA; Hansbro PM; Payne RJ; Britton WJ
Nat Commun; 2022 Nov; 13(1):6972. PubMed ID: 36379950
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
Fröberg J; Diavatopoulos DA
Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
7. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
[TBL] [Abstract][Full Text] [Related]
8. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.
Tang J; Zeng C; Cox TM; Li C; Son YM; Cheon IS; Wu Y; Behl S; Taylor JJ; Chakaraborty R; Johnson AJ; Shiavo DN; Utz JP; Reisenauer JS; Midthun DE; Mullon JJ; Edell ES; Alameh MG; Borish L; Teague WG; Kaplan MH; Weissman D; Kern R; Hu H; Vassallo R; Liu SL; Sun J
Sci Immunol; 2022 Oct; 7(76):eadd4853. PubMed ID: 35857583
[TBL] [Abstract][Full Text] [Related]
9. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.
Farooq M; Khan AW; Ahmad B; Kim MS; Choi S
Front Pharmacol; 2022; 13():915565. PubMed ID: 35847031
[TBL] [Abstract][Full Text] [Related]
12. The Human Nose Organoid Respiratory Virus Model: an
Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
[TBL] [Abstract][Full Text] [Related]
13. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
14. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
Noor R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150
[TBL] [Abstract][Full Text] [Related]
15. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R; Kalmarzi RN; Roghani SA
Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
[TBL] [Abstract][Full Text] [Related]
16. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
[TBL] [Abstract][Full Text] [Related]
17. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists.
Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ
Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.
Pilapitiya D; Wheatley AK; Tan HX
EBioMedicine; 2023 Jun; 92():104585. PubMed ID: 37146404
[TBL] [Abstract][Full Text] [Related]
19. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
Ramasamy R
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
[TBL] [Abstract][Full Text] [Related]
20. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Mitsi E; Diniz MO; Reiné J; Collins AM; Robinson RE; Hyder-Wright A; Farrar M; Liatsikos K; Hamilton J; Onyema O; Urban BC; Solórzano C; Belij-Rammerstorfer S; Sheehan E; Lambe T; Draper SJ; Weiskopf D; Sette A; Maini MK; Ferreira DM
Nat Commun; 2023 Oct; 14(1):6815. PubMed ID: 37884506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
